Nectar Lifesciences on Tuesday, 14 April 2020, announced that it has started limited operations of its API (active pharmaceutical ingredient) plants in Derabassi, Punjab.
The company, however, said that its plants in Baddi, Himachal Pradesh are still inoperational due to lack of manpower and logistics issues.
Nectar Lifesciences' consolidated net profit tanked 24.66% to Rs 8.22 crore on a 11.55% fall in net sales to Rs 647.96 crore in Q3 December 2019 over Q3 December 2018.
Nectar Lifesciences is engaged in manufacturing and delivering pharmaceutical products.
Shares of Nectar Lifesciences declined 3.73% to close at Rs 15.23 on BSE on Monday, 13 April 2020. The stock has risen 111.52% from its record low of Rs 7.20 hit on 13 March 2020.
The stock exchanges are closed today, 14 April 2020, on account of Ambedkar Jayanti.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app